Showing results (101-110 of 136) with videos related to

Sort By:
Pageof 14
Annals of Surgical Oncology|July 25, 2012
Circulating endothelial cell (CEC) as a diagnostic and prognostic marker in malignant pleural mesothelioma (MPM)Kazue Yoneda, Fumihiro Tanaka, Nobuyuki Kondo, et al.
Annals of Surgical Oncology|December 6, 2013
Circulating tumor cells (CTCs) in malignant pleural mesothelioma (MPM)Kazue Yoneda, Fumihiro Tanaka, Nobuyuki Kondo, et al.
Journal of Gastroenterology|August 8, 2014
Food antigen-induced immune responses in Crohn's disease patients and experimental colitis miceTakaaki Kawaguchi, Maiko Mori, Keiko Saito, et al.
Cancer Immunology, Immunotherapy : CII|September 14, 2022
Effectiveness of pembrolizumab in trial-ineligible patients with metastatic urothelial carcinomaWataru Fukuokaya, Takafumi Yanagisawa, Masaki Hashimoto, et al.
International Cancer Conference Journal|January 27, 2026
Pathological diagnosis and therapeutic management of hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cell carcinomaKojiro Tashiro, Yoji Nagashima, Mikiko Kaneko, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|January 19, 2025
[UPFRONT DOCETAXEL WITH ANDROGEN DEPRIVATION THERAPY IN MALES WITH HIGH-VOLUME METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER: RESULTS OF A SINGLE-INSTITUTION SERIES]Kenichi Hata, Masaki Hashimoto, Yusuke Takahashi, et al.
International Journal of Clinical Oncology|March 2, 2024
Association between comorbidities and survival in patients with metastatic urothelial carcinoma treated with pembrolizumabMasaki Hashimoto, Wataru Fukuokaya, Takafumi Yanagisawa, et al.
Plos One|October 17, 2015
Decreased Plasma Histidine Level Predicts Risk of Relapse in Patients with Ulcerative Colitis in RemissionTadakazu Hisamatsu, Nobukazu Ono, Akira Imaizumi, et al.
Pageof 14